Skip to Content
MoleculesMolecules
  • Article
  • Open Access

28 September 2019

18 Pages

Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents †

,
,
,
,
,
,
,
and
1
Dipartimento di Farmacia, Università di Pisa, Via Bonanno 33, 56126 Pisa, Italy
2
Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via G. Moruzzi 3, 56124 Pisa, Italy
*
Authors to whom correspondence should be addressed.
†
Dedicated to the beloved memory of Prof. Cinzia Chiappe.
This article belongs to the Section Bioorganic Chemistry

Abstract

Conjugation of known biologically active molecules to carbohydrate frameworks represents a valuable option for the preparation of hybrid, structurally-related families of compounds with the aim of modulating their biological response. Therefore, we present here a study on the preparation of d-galacto, d-manno, d-gluco, and d-lactose glycoconjugates of an established N-hydroxyindole-based (NHI) inhibitor of lactated dehydrogenase (LDH). Structural variations involved the sugar stereochemistry and size as well as the anchoring point of the NHI on the carbohydrate frame (either C-1 or C-6). In the case of the galactose anomeric glycoconjugate (C-1), intriguing solvent-dependent effects were observed in the glycosylation stereochemical outcome. The biological activity of the deprotected glycoconjugates in contrasting lactate formation and cancer cell proliferation are described.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.